PW01-033 – Phenotype – genotype in Armenian children with FMF by unknown
MEETING ABSTRACT Open Access
PW01-033 – Phenotype – genotype in Armenian
children with FMF
G Amaryan1*, T Sarkissian2, T Sarkissian2, H Hayrapetyan2, H Hayrapetyan2, A Tadevosyan3, A Tadevosyan3
From 7th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Lausanne, Switerland. 22-26 May 2013
Introduction
Familial Mediterranean Fever (FMF) is an ethnic disease
for Armenian population and represents a significant
health care problem. Frequency of carriers of MEFV
mutations is 1:3, and the prevalence of FMF is rather
high (14-100:10000). During the period between 2003
and 2012 there was a 4.5-fold increase of the total num-
ber of children with FMF. Many of these cases have
severe clinical picture and atypical course, which may
complicate timely diagnosis.
Objectives
To establish phenotype-genotype correlations in Armenian
children with FMF
Methods
We analyzed a group of 715 children with FMF (438 boys
and 277 girls, mean age: 8.64±0.17), including sporadic
(51.8%) and familial cases (48.2%). The diagnosis was
based on the Tel-Hashomer criteria, the “Guidelines for
the genetic diagnosis of hereditary recurrent fevers”(2011)
and molecular-genetic detection of 12 MEFV mutations
common for Armenians. The statistical analysis was per-
formed using Epi-Info 2000 software. For comparison of
two nominal variables in table “two by two” Yaet’s cor-
rected for continuity chi-square test was used, significance
level p<0.05.
Results
FMF manifestation during the first decade of life were
determined in 95.2% of patients (mean age of onset 3.5
±0.1, mean age of diagnosis 5.25±0.15). FMF onset before
5 years was in 78.6%. In 96.5% of patients severe phenotype
with polyserositis was associated with MEFV mutations in
exon 10 (M694V- 58.1%; V726A- 20.4%; M680I- 15.7%). In
contrast, mild or atypical FMF phenotypes without polyser-
ositis were found in heterozygous carriers of one MEFV
mutation in exons 2 and 3 (E148Q and P369S, respec-
tively). We suggest that our patients with FMF developed
pleurisy more frequently (81.7%), also myalgia (37.5%),
pericarditis (13.8%), and rare skin lesions (13.4%) mostly as
erysipelas-like erythema, ELE, (10.8%) in comparison with
other populations (Jews, Turks, Arabs).
Among concurrent pathologies, we found Henoch-
Shonlein purpura (HSP,1.5%), protracted febrile myalgia
(PFM, 2.7%) as well as the higher than expected frequen-
cies for juvenile idiopathic arthritis (JIA, 4.7%), non-amy-
loid renal involvements (NARI, 1.1%) and ulcerative
colitis/Crohn’s disease (UC/CD, 1%). The development of
serositis, splenomegaly, ELE and vasculitis was associated
with M694 homozygous and compound-heterozygous
genotypes. Early manifestation and severe FMF attacks
were detected in patients carrying M694Vgenotypes,
whereas the M680I and V726A mutations were associated
with relatively mild clinical features. Adhesive intestinal
obstruction (AIO), was detected in 3.2% of patients, in
some cases as the first and only FMF manifestation, espe-
cially in theM694Vcarriers.
Conclusion
Taking into account the high prevalence of FMF in Arme-
nia, MEFV mutation screening is recommended not only
for patients with atypical symptoms resembling FMF, but
also for patients with FMF- associated vasculitis (HSP,
PFM) as well as co-existed immune diseases (JIA, NARI,
UC/CD) and AIO. In addition to improving the early diag-
nosis of FMF and preventing the development of amyloi-
dosis, this can be especially important in the patients
resistant to conventional treatments for the aforemen-
tioned FMF-associated and other concurrent diseases.
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